In cancer, documented cases of DNA amplification at 11q13, primarily likely selecting for CCND1 proto-oncogene activation, often correspond to elevated MYEOV expression and an unfavourable prognosis (Fang et al., 2019; Liang et al., 2020). The gene discussed is MYEOV; the disease is cancer.